No Matches Found
No Matches Found
No Matches Found
Dhanvantri Jeevan Rekha Ltd
Are Dhanvantri Jeevan Rekha Ltd latest results good or bad?
Dhanvantri Jeevan Rekha Ltd's latest Q3 FY26 results show a strong operational recovery with net sales up 27.54% and a net profit increase of 13.33%. However, concerns remain regarding capital efficiency and a high P/E ratio of 104x, indicating potential valuation issues despite the positive growth.
Dhanvantri Jeevan Rekha Q3 FY26: Operational Recovery Masks Underlying Fragility
Dhanvantri Jeevan Rekha Ltd., a micro-cap healthcare services provider based in Meerut, reported a sharp operational turnaround in Q3 FY26, posting net profit of ₹0.17 crores—a dramatic recovery from the ₹0.14 crore loss recorded in Q2 FY26. However, with a market capitalisation of just ₹10.00 crores and elevated valuation metrics, the company's financial fragility remains a significant concern for investors despite the sequential improvement.
Are Dhanvantri Jeevan Rekha Ltd latest results good or bad?
Dhanvantri Jeevan Rekha Ltd's latest results are concerning, showing a net profit decline to -₹0.14 crores despite a 7.75% revenue growth, highlighting significant operational challenges and negative profitability metrics. The company needs to address rising costs and improve efficiency to enhance its financial performance.
When is the next results date for Dhanvantri Jeevan Rekha Ltd?
The next results date for Dhanvantri Jeevan Rekha Ltd is 12 February 2026.
Dhanvantri Jeevan Rekha Ltd Downgraded to Sell Amid Mixed Technicals and Weak Fundamentals
Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 4 February 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent fundamental challenges. The upgrade is driven primarily by improvements in technical indicators, while valuation and financial trends remain subdued, underscoring a cautious stance for investors.
Dhanvantri Jeevan Rekha Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Fundamentals
Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 30 Jan 2026. Despite some mild technical improvements, the company’s weak financial trends and poor valuation metrics have weighed heavily on its overall assessment, prompting a reassessment of its investment appeal.
Why is Dhanvantri Jeevan Rekha Ltd falling/rising?
On 13-Jan, Dhanvantri Jeevan Rekha Ltd witnessed a notable decline in its share price, falling by 4.97% to close at ₹23.32. This drop reflects a broader pattern of underperformance relative to both its sector and the benchmark Sensex index, amid signs of erratic trading and shifting investor participation.
Dhanvantri Jeevan Rekha Ltd is Rated Sell
Dhanvantri Jeevan Rekha Ltd is rated Sell by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook.
Dhanvantri Jeev. Sees Revision in Market Evaluation Amidst Mixed Financial Signals
Dhanvantri Jeev., a microcap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, signalling a more cautious stance from market analysts.
Dhanvantri Jeevan Rekha Sees Unprecedented Buying Interest Amid Upper Circuit Lock
Dhanvantri Jeevan Rekha Ltd has attracted extraordinary buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals robust demand and the possibility of a multi-day circuit scenario, underscoring heightened investor enthusiasm in the healthcare services sector.
Dhanvantri Jeevan Rekha Sees Unprecedented Buying Interest Amid Upper Circuit Scenario
Dhanvantri Jeevan Rekha Ltd, a key player in the healthcare services sector, has attracted extraordinary buying interest, resulting in an upper circuit situation with only buy orders in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting robust demand and investor enthusiasm despite mixed performance metrics over various time frames.
Dhanvantri Jeevan Rekha Sees Unprecedented Buying Interest, Edges Into Multi-Day Upper Circuit Territory
Dhanvantri Jeevan Rekha Ltd has captured market attention with extraordinary buying momentum, registering a 4.99% gain today and hitting an upper circuit with exclusively buy orders in the queue. This rare scenario signals robust investor enthusiasm and the potential for a sustained multi-day circuit, setting the healthcare services stock apart from broader market trends.
Dhanvantri Jeevan Rekha Sees Extraordinary Buying Interest Amid Upper Circuit Scenario
Dhanvantri Jeevan Rekha Ltd, a key player in the Healthcare Services sector, has attracted remarkable buying interest today, with the stock hitting an upper circuit and registering exclusively buy orders in the queue. This unusual market behaviour signals a potential multi-day circuit scenario, reflecting strong investor enthusiasm despite recent mixed performance trends.
Dhanvantri Jeevan Rekha Sees Unprecedented Buying Interest Amid Upper Circuit Scenario
Dhanvantri Jeevan Rekha Ltd has attracted extraordinary buying interest on 27 Nov 2025, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a strong demand surge, potentially extending the circuit scenario over multiple trading sessions as sellers remain absent.
Dhanvantri Jeevan Rekha Sees Unprecedented Buying Interest Amid Upper Circuit Scenario
Dhanvantri Jeevan Rekha Ltd has attracted extraordinary buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand in the healthcare services sector despite recent price fluctuations.
Dhanvantri Jeevan Rekha Sees Unprecedented Buying Interest Amid Upper Circuit Scenario
Dhanvantri Jeevan Rekha Ltd has attracted extraordinary buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon signals robust demand and the potential for a multi-day circuit scenario, underscoring the stock’s prominence within the healthcare services sector.
Dhanvantri Jeevan Rekha Faces Intense Selling Pressure Amid Lower Circuit Lock
Dhanvantri Jeevan Rekha Ltd has encountered severe selling pressure, with the stock hitting the lower circuit and registering only sell orders in the queue. This development signals distress selling and a lack of buyer interest, marking a significant moment for the healthcare services company amid volatile market conditions.
Dhanvantri Jeevan Rekha Surges with Unprecedented Buying Interest, Eyes Multi-Day Upper Circuit
Dhanvantri Jeevan Rekha Ltd has captured market attention with extraordinary buying momentum, registering a 4.99% gain today while trading exclusively at the upper circuit price with no sellers in queue. This rare scenario signals a potential multi-day circuit lock, reflecting robust investor enthusiasm in the healthcare services sector amid broader market fluctuations.
Dhanvantri Jeevan Rekha Hits Upper Circuit Amidst Unprecedented Buying Interest
Dhanvantri Jeevan Rekha Ltd has witnessed extraordinary buying momentum today, hitting the upper circuit with no sellers in the queue. This rare market phenomenon highlights intense demand for the healthcare services stock, suggesting a potential multi-day circuit scenario as investors continue to show strong conviction.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
